These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 31129934)

  • 1. Recent advances in management of type 1 diabetes.
    Pyrlis F; Brown F; Ekinci EI
    Aust J Gen Pract; 2019 May; 48(5):256-261. PubMed ID: 31129934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Semi-closed-loop insulin delivery systems: early experience with low-glucose insulin suspend pumps.
    Pickup JC
    Diabetes Technol Ther; 2011 Jul; 13(7):695-8. PubMed ID: 21668344
    [No Abstract]   [Full Text] [Related]  

  • 3. Type 1 diabetes technology: advances and challenges.
    The Lancet Diabetes Endocrinology
    Lancet Diabetes Endocrinol; 2019 Sep; 7(9):657. PubMed ID: 31439271
    [No Abstract]   [Full Text] [Related]  

  • 4. Diabetes Technology Use in Adults with Type 1 and Type 2 Diabetes.
    Kravarusic J; Aleppo G
    Endocrinol Metab Clin North Am; 2020 Mar; 49(1):37-55. PubMed ID: 31980120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Diabetes Technology in Children: Role of Structured Education for Young People with Diabetes and Families.
    Desrochers HR; Schultz AT; Laffel LM
    Endocrinol Metab Clin North Am; 2020 Mar; 49(1):19-35. PubMed ID: 31980118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefits and Challenges of Diabetes Technology Use in Older Adults.
    Toschi E; Munshi MN
    Endocrinol Metab Clin North Am; 2020 Mar; 49(1):57-67. PubMed ID: 31980121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replacement of Blood Glucose Measurements by Measurements With Systems for Real-Time Continuous Glucose Monitoring (rtCGM) or CGM With Intermittent Scanning (iscCGM): A German View.
    Freckmann G; Schlüter S; Heinemann L;
    J Diabetes Sci Technol; 2017 Jul; 11(4):653-656. PubMed ID: 28745088
    [No Abstract]   [Full Text] [Related]  

  • 8. Persistent heterogeneity in diabetes technology reimbursement for children with type 1 diabetes: The SWEET perspective.
    Sumnik Z; Szypowska A; Iotova V; Bratina N; Cherubini V; Forsander G; Jali S; Raposo JF; Stipančic G; Vazeou A; Veeze H; Lange K;
    Pediatr Diabetes; 2019 Jun; 20(4):434-443. PubMed ID: 30773756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming type 1 diabetes: the next wave of innovation.
    Drucker DJ
    Diabetologia; 2021 May; 64(5):1059-1065. PubMed ID: 33550440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes Technology and the Human Factor.
    Liberman A; Barnard K
    Diabetes Technol Ther; 2018 Feb; 20(S1):S128-S138. PubMed ID: 29437474
    [No Abstract]   [Full Text] [Related]  

  • 11. Emerging Technologies for Diabetes Care.
    Bailey TS; Walsh J; Stone JY
    Diabetes Technol Ther; 2018 Jun; 20(S2):S278-S284. PubMed ID: 29916738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automated Insulin Delivery in Children with Type 1 Diabetes.
    Cengiz E
    Endocrinol Metab Clin North Am; 2020 Mar; 49(1):157-166. PubMed ID: 31980115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Technological Revolution: The Integration of New Treatments to Manage Type 1 Diabetes.
    Galderisi A; Sherr JL
    Pediatr Ann; 2019 Aug; 48(8):e311-e318. PubMed ID: 31426099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Insulin pump regulated by a glucose sensor; one step closer to closing the loop for type 1 diabetes patients].
    de Valk HW
    Ned Tijdschr Geneeskd; 2019 Sep; 163():. PubMed ID: 31556504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variations in access to and reimbursement for continuous glucose monitoring systems for people living with Type 1 diabetes across England.
    Perera R; Oliver N; Wilmot E; Marriott C
    Diabet Med; 2018 Nov; 35(11):1617-1618. PubMed ID: 29931731
    [No Abstract]   [Full Text] [Related]  

  • 16. Numerical and clinical precision of continuous glucose monitoring in Colombian patients treated with insulin infusion pump with automated suspension in hypoglycemia.
    Gómez AM; Marín Sánchez A; Muñoz OM; Colón Peña CA
    Endocrinol Nutr; 2015 Dec; 62(10):485-92. PubMed ID: 26531841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin Pumps.
    Pickup JC
    Diabetes Technol Ther; 2018 Feb; 20(S1):S30-S40. PubMed ID: 29437475
    [No Abstract]   [Full Text] [Related]  

  • 18. Cost calculation for a flash glucose monitoring system for UK adults with type 1 diabetes mellitus receiving intensive insulin treatment.
    Hellmund R; Weitgasser R; Blissett D
    Diabetes Res Clin Pract; 2018 Apr; 138():193-200. PubMed ID: 29410149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-world evidence for computerized insulin dose-adjustment algorithms in the effective use of continuous glucose monitoring by primary care clinicians.
    Davidson MB; Davidson SJ
    Diabetes Obes Metab; 2024 Aug; 26(8):3475-3477. PubMed ID: 38860407
    [No Abstract]   [Full Text] [Related]  

  • 20. Insulin Infusion Sets and Continuous Glucose Monitoring Sensors: Where the Artificial Pancreas Meets the Patient.
    Forlenza GP
    Diabetes Technol Ther; 2017 Apr; 19(4):206-208. PubMed ID: 28418732
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.